TenNor Therapeutics (Suzhou) Ltd, 2026-05-26
An SEC Form D private-offering notice from Suzhou, a $14,699,667 filer-stated offering target in Biotech. Filed 2026-05-26. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Suzhou, China based clinical stage biotech developing therapies for bacterial infection and metabolic disease, including its lead H. pylori drug candidate rifasutenizol.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Vivamed, Inc., 2026-05-27, $3M, Santa Monica, CA
- Reprogram Biosciences, Inc., 2026-05-26, $5M, San Carlos, CA
- ONCOSYNERGY, INC., 2026-05-26, $8.2M, Stamford, CT
- ViCardia Therapeutics, Inc., 2026-05-21, $700K, San Francisco, CA
- Conexeu Sciences Inc., 2026-05-21, $45K, Reno, NV
- beyondGREEN biotech Inc., 2026-05-21, Santa Ana, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.